# FDA Inspection 1225075 - Gregory J. Feldman, M.D. - November 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/gregory-j-feldman-md/7b97b611-8662-4f20-82b1-c95f5654b95a
Source feed: FDA_Inspections

> FDA Inspection 1225075 for Gregory J. Feldman, M.D. on November 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225075
- Company Name: Gregory J. Feldman, M.D.
- Inspection Date: 2023-11-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1103574 - 2019-09-20](https://www.keypedia.com/records/fda_inspections/gregory-j-feldman-md/2ebc040f-1165-41f1-afde-9dec5f9f8ca5)
- [FDA Inspection 834451 - 2013-05-10](https://www.keypedia.com/records/fda_inspections/gregory-j-feldman-md/031ac2fd-8d3f-4ca7-91de-8cc8c318ae55)

Company: https://www.keypedia.com/companies/gregory-j-feldman-md/596e6cb1-b599-4054-b285-8f040381e17d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d